Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Cardiovascular
Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care – a multi-state survival model based on a randomized controlled trial
Lan Gaoa Deakin Health Economics, Institute for Health Transformation, Deakin University, Geelong, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0001-9734-1140
https://orcid.org/0000-0001-9734-1140, Paul Scuffhamb Menzies Health Institute Queensland, Griffith University, Gold Coast, Australiahttps://orcid.org/0000-0001-5931-642X
https://orcid.org/0000-0001-5931-642X, Jocasta Ballc Centre for Research and Evaluation, Ambulance Victoria, Blackburn North, Australia;d Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Australiahttps://orcid.org/0000-0002-1512-4255
https://orcid.org/0000-0002-1512-4255, Simon Stewarte Torrens University, Adelaide, Australiahttps://orcid.org/0000-0001-9032-8998
https://orcid.org/0000-0001-9032-8998 & Joshua Byrnesf Centre for Applied Health Economics, Griffith University, Nathan, Australiahttps://orcid.org/0000-0001-6562-711X
https://orcid.org/0000-0001-6562-711XRelated Research Data
Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care – a multi-state survival model based on a randomized controlled trial
Source:
Taylor & Francis
Linking provided by
